Atuss Da
NDC Package 58407-252-16

11-digit billing NDC: 58407025216

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Atuss Da is uses temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: cough due to minor throat and bronchial irritationnasal congestionreduces swelling of nasal passagesrunny nosesneezingitchy, watery eyesitching of the nose or throat. Marketed by Magna Pharmceuticals, Inc., this product is identified by NDC 58407-252 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
58407-252-16
Package Description
473 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
58407025216
RxNorm Crosswalk
  • RxCUI: 1014331 - brompheniramine maleate 2 MG / chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution
  • RxCUI: 1014331 - brompheniramine maleate 0.4 MG/ML / chlophedianol hydrochloride 2.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution
  • RxCUI: 1014331 - brompheniramine maleate 2 MG / chlophedianol hydrochloride 12.5 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Atuss Da
Dosage Form
-
Usage Information
Uses temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: cough due to minor throat and bronchial irritationnasal congestionreduces swelling of nasal passagesrunny nosesneezingitchy, watery eyesitching of the nose or throat

Regulatory & Marketing

Labeler Name
Magna Pharmceuticals, Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
11-20-2018
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (58407-252). Click a package code to view its specific billing and regulatory data.

6 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE
118 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58407-252-16 identifies a specific commercial package of 473 ml in 1 bottle of Atuss Da, labeled by Magna Pharmceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Magna Pharmceuticals, Inc. on November 20, 2018. The current certification is valid through December 31, 2022.

How is this Magna Pharmceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58407025216. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58407-252-16
11-Digit CMS (5-4-2)
58407-0252-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.